Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Selinexor in Advanced Liposarcoma

Sarcoma

This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2-3 study of patients diagnosed with advanced unresectable dedifferentiated liposarcoma. Approximately 279 total patients will be randomized to study treatment (selinexor or placebo).
Sarcoma
II/III
Davis, Elizabeth
NCT02606461
VICCSAR1879

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: